Clinical Trials Browser

Phase 2 × OTHER × HER2 Positive Esophagogastric Cancer × Clear all

NCT01769508 2016-06-13

Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer

Phase 2 Terminated

12 enrolled 8 charts

Gastrointestinal

HER2 Positive Esophagogastric Cancer